CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today reported that A. Ernest Whiton, its Chief Financial Officer and Vice President of Administration, is entering into a 10b5-1 sales plan for the sale of up to 80,000 shares of ZOLL common stock over an approximate 12-month period. It is expected that Mr. Whiton will sell approximately 15,000 to 20,000 shares each quarter pursuant to the Plan, depending on market conditions. Sales under the plan will commence in the first quarter of fiscal 2009. The shares to be sold will be acquired upon the exercise of a portion of stock options which were granted to Mr. Whiton over the past several years. This new plan follows 10b5-1 sales plans entered into by Mr. Whiton in September 2006 and September 2007.
